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ABSTRACT Bovine tuberculosis has been an escalating animal health issue in the
United Kingdom since the 1980s, even though control policies have been in place
for over 60 years. The importance of the genetics of the etiological agent, Mycobac-
terium bovis, in the reemergence of the disease has been largely overlooked. We
compared the interaction between bovine monocyte-derived macrophages (bMDM)
and two M. bovis strains, AF2122/97 and G18, representing distinct genotypes cur-
rently circulating in the United Kingdom. These M. bovis strains exhibited differences
in survival and growth in bMDM. Although uptake was similar, the number of viable
intracellular AF2122/97 organisms increased rapidly, while G18 growth was con-
strained for the ﬁrst 24 h. AF2122/97 infection induced a greater transcriptional re-
sponse by bMDM than G18 infection with respect to the number of differentially ex-
pressed genes and the fold changes measured. AF2122/97 infection induced more
bMDM cell death, with characteristics of necrosis and apoptosis, more inﬂammasome
activation, and a greater type I interferon response than G18. In conclusion, the two
investigated M. bovis strains interact in signiﬁcantly different ways with the host
macrophage. In contrast to the relatively silent infection by G18, AF2122/97 induces
greater signaling to attract other immune cells and induces host cell death, which
may promote secondary infections of naive macrophages. These differences may af-
fect early events in the host-pathogen interaction, including granuloma develop-
ment, which could in turn alter the progression of the disease. Therefore, the poten-
tial involvement of M. bovis genotypes in the reemergence of bovine tuberculosis in
the United Kingdom warrants further investigation.
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Bovine tuberculosis (TB), caused by Mycobacterium bovis, is a disease of cattle ofglobal importance (1). Despite control measures having been in place in the United
Kingdom since the 1950s, including a strict test and slaughter policy, the incidence of
the disease is increasing in many areas of the country, especially southwest England (2,
3). Additional or alternative methods of control are therefore needed, the development
of which will require a greater understanding of the biology of the disease. A number
of herd- and animal-level factors have been identiﬁed which increase the risk of bovine
TB. These include host genetics; Bos indicus cattle are more resistant than Bos taurus
breeds (reviewed in reference 4). Furthermore, it has been calculated that within the
Irish and UK beef and dairy herds, up to 20% of variation in TB resistance is accounted
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for by cattle genetics (5–9). In addition, regions of the bovine genome have been
associated with TB susceptibility in Holstein-Friesian dairy cattle (6, 10–12). Other risk
factors include farm management practices, e.g., cattle movement, herd size, environ-
mental factors, and presence of infectious wildlife reservoirs (reviewed in reference 13).
The importance of the genetics of the etiological agent in the resurgence of bovine
TB has received relatively less attention, possibly because of the apparently limited
variability inM. bovis genotypes.M. bovis is a member of theMycobacterium tuberculosis
complex (MTBC), members of which cause similar pathology in a wide variety of
mammals and have evolved from a common ancestor by mutations and deletions with
limited evidence of recombination of genetic material in more modern lineages (14).
The causative agent of human TB, M. tuberculosis, and the bovine pathogen, M. bovis,
are located in different lineages of the MTBC (14), yet they share, on average, 99.95%
sequence homology, although the M. bovis genome is smaller due to deletion events
(15). The current limited genetic diversity of the M. bovis population in the United
Kingdom compared with the diversity of genotypes seen elsewhere, e.g., in France,
suggests that it has undergone a population bottleneck, which may be the result of the
test-and-slaughter policy restricting variation (16). However, since this bottleneck, M.
bovis has diversiﬁed in isolation in different geographical regions of the United King-
dom (17), and clonal sublineages can be identiﬁed which are the predicted descen-
dants of a common ancestor, identiﬁable by characteristic mutations and deletions (18).
Fortunately, it has been shown that in Northern Ireland the M. bovis genotype does not
signiﬁcantly affect the accuracy of the tuberculin skin test, which is used to detect
infected animals (19). However, these genotypes can be separated according to viru-
lence determined by the proportion of skin test-positive animals which have visible
granulomas on postmortem inspection (20).
The principal route ofM. bovis infection is inhalation into the bovine lung, where the
mycobacteria are phagocytosed by alveolar macrophages (M) (reviewed in reference
21). Within these innate immune cells pathogenic mycobacteria survive and multiply by
inducing profound changes in M biology (reviewed in reference 22). These early
interactions are likely to play an important role in determining the progression of the
disease. Previous work infecting bovine alveolar M in vitro with virulent and attenu-
ated M. bovis revealed differences in the transcriptional response of infected cells (23).
Furthermore, it has been shown that differences in growth ofM. bovis isolates in bovine
monocyte-derived M (bMDM) (24) correlated with virulence in a mouse model (25).
During infection, differences in the transcriptomic response of these virulent and
attenuatedM. bovis strains and that of the infected bMDM have been identiﬁed (24, 26).
Therefore, we hypothesized that M. bovis strains currently circulating in the United
Kingdom also exhibit differences in their interaction with host cells, which may inﬂu-
ence the pathology of the disease. To further our understanding of the interplay
between M. bovis and the host cell, we investigated and compared the infection of
bMDM with two UK isolates of M. bovis. The isolates used were the ﬁrst M. bovis ﬁeld
isolate subjected to bacterial whole-genome sequencing (15), AF2122/97, which is
widely considered a reference strain of M. bovis and frequently used in experimental
infection studies (27, 28), and strain G18, which is relatively divergent both geograph-
ically and genetically from AF2122/97. Signiﬁcant differences were found in the intra-
cellular growth and survival of the M. bovis strains, the survival of infected bMDM, and
the bMDM transcriptional response.
RESULTS
Dynamics of M. bovis infection of bMDM. The uptake, survival, and proliferation
of the two strains of M. bovis (AF2122/97 and G18) during in vitro infection of bMDM
were investigated by quantifying the number of intracellular mycobacteria by two
methods. Quantiﬁcation of genome copy number (GCN) by quantitative PCR (qPCR),
which does not distinguish between active and inactivated mycobacteria, identiﬁed a
signiﬁcant difference in growth rate between these twoM. bovis strains (P 0.001) (Fig.
1, solid lines). The numbers of intracellular AF2122/97 (here called AF2122) and G18
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were not signiﬁcantly different 2 h postinfection (hpi), with average M. bovis/bMDM
ratios of 0.85 and 0.98, respectively. However, from 24 hpi there were signiﬁcantly more
AF2122 organisms per cell than G18 organisms. The number of AF2122 organisms
increased consistently between 24 and 72 hpi, while the increase in G18 numbers
lessened between 48 h and 72 h, and at the ﬁnal time point there were, on average,
3.7  0.5 times more AF2122 organisms per cell than G18 organisms.
Quantiﬁcation of CFU, which measures the number of active mycobacteria, revealed
an overall similar pattern of growth rate differences between the two strains, with no
signiﬁcant difference 2 hpi but signiﬁcantly different growth rates over the subsequent
time course (P  0.001) (Fig. 1, dotted lines). However, the CFU counts were signiﬁ-
cantly lower than the GCN counts at 2 hpi (P  0.001), with, on average, 0.4  0.1 and
0.5  0.1 CFU per bMDM for AF2122 and G18, respectively. M. bovis bacilli are prone
to form clumps, which could lead to an underestimation of the number of CFU and
account for this difference. Alternatively, it may relate to the bactericidal activity of
bMDM rapidly inactivating the mycobacteria. The quantiﬁcation by CFU revealed
considerable differences in intracellular growth, especially during the ﬁrst 24 h of
infection. AF2122 CFU increased rapidly, so that there were 2.1 0.4 AF2122 organisms
per cell by 24 hpi and the GCN/CFU ratio was reduced from 2.9:1 at 2 hpi to 1.5:1 by
24 hpi. AF2122 numbers increased over the remainder of the time course at a similar,
but slightly lower, rate than the increase in GCN to give a ﬁnal GCN/CFU ratio of 2.4:1.
In contrast, the average G18 CFU count decreased slightly during the ﬁrst 24 h, and the
GCN/CFU ratio was 3.4:1 at 24 hpi. Thereafter the G18 CFU increased at a higher rate
than the GCN, so that the GCN/CFU ratio was reduced to 1.9:1 at 72 hpi. Therefore, the
difference in the number of live AF2122 and G18 organisms narrowed throughout the
time course, with 4.4  0.7 times more AF2122 than G18 at 24 hpi but only 2.8  0.3
times more at 72 hpi. The CFU quantiﬁcation revealed that between 2 hpi and 72 hpi
AF2122 had undergone approximately four rounds of replication, giving a doubling
time of 17.5 h. In contrast, G18 had undergone two rounds of replication in the same
period, giving a doubling time of 35 h. However, between 24 hpi and 72 hpi the
doubling time of AF2122 was slower than that of G18, at approximately 30 h, with half
the replication occurring during the ﬁrst 24 h of infection. Therefore, the two M. bovis
FIG 1 Survival and proliferation of M. bovis strains in bMDM differ. The graph compares the number of M.
bovis organisms in bMDM throughout the 72-h time course. M. bovis organisms were quantiﬁed by qPCR
(solid lines) and CFU (dotted lines) for AF2122 (green squares) and G18 (blue triangles). Error bars denote
the standard errors from three biological replicates.
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strains vary in their ability to survive and grow in these bMDM, which suggests
differences in the host-pathogen interactions occurring during in vitro infection. The
mechanisms behind these differences may be elucidated by investigating the tran-
scriptional response of bMDM during infection.
Analysis of RNA-Seq data. RNA sequencing (RNA-Seq) was employed to investi-
gate the response of bMDM to infection with the two strains of M. bovis, AF2122 and
G18. Differentially expressed genes were identiﬁed by comparing their transcriptional
levels in response to each M. bovis infection to that in uninfected control samples at
each time point (false discovery rate of 1%). The differentially expressed genes are
summarized in Fig. 2A and are listed in full in Data Set S1 in the supplemental material.
The overall patterns of response to both M. bovis strains were similar. The greatest
FIG 2 Comparison of the bMDM transcriptional response to M. bovis strains. (A) Graph summarizing the
transcriptional response of bMDM to the M. bovis strains at each time point compared to those of the
uninfected controls identiﬁed by analysis of the RNA-Seq data. The bars represent the number of genes
differentially expressed speciﬁcally in response to AF2122 (green bars) or G18 (blue bars) and the common
transcriptional response (striped bars). The numbers above the green and blue bars denote the percentages
of genes that were upregulated in response to AF2122 and G18 infection, respectively, at each time point.
(B) Graph illustrating the average fold change quantiﬁed by analysis of the RNA-Seq data of 702 differen-
tially expressed genes which overlap the AF2122_6h (green dots) and G18_6h (blue dots) gene lists. The
genes are shown in ascending order of differential expression in response to G18.
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number of differentially expressed genes was observed 6 hpi. With the exception of 2
hpi, a greater number of genes were differentially expressed in response to AF2122
than G18. In response to both M. bovis strains there was a bias toward upregulated
genes at all time points, which was greatest in the G18_2h gene list, with only 10.1%
differentially expressed genes being downregulated. The ratios of up- and downregu-
lated genes were most similar in the 6-h gene lists, with 37.3% and 38.7% of differen-
tially expressed genes being downregulated in AF2122_6h and G18_6h gene lists,
respectively.
Comparison of the AF2122 and G18 gene lists at each time point revealed that the
greatest overlap was in the response of bMDMs to the two M. bovis strains at the earlier
time points (Fig. 2A). Approximately half the genes were differentially expressed in
response to both AF2122 and G18 at 2 hpi and 6 hpi, with 220 and 702 genes,
respectively. The level of overlap in differentially expressed genes dropped at the later
time points, 27.2% and 36.9% at 24 hpi and 48 hpi, respectively, indicating that the
bMDM responses to the two M. bovis strains diverge with time. However, within the
common differentially expressed genes there was further evidence of a greater re-
sponse to AF2122 than G18. The expression of the common response genes was
predominantly affected to a greater extent following infection with AF2122 than G18.
This was observed at all four time points, e.g., at 6 hpi the expression of only 86 out of
702 common response genes (12.3%) was altered to a greater degree in response to
G18 than AF2122 (Fig. 2B).
Combining the differentially expressed gene lists for infections with both M. bovis
strains and comparing the transcriptional response over time suggested that there was
a biphasic response of bMDM to M. bovis infection, with an early response (2 h and 6
h) and a later response (24 h and 48 h). The greatest temporal overlap in differentially
expressed genes was observed between 24-h and 48-h time points, with 38.9% genes
differentially expressed at both time points. In contrast, only 12.0 to 14.4% of genes
overlapped between the early and late time points compared with 21.6% between the
2-h and 6-h time points (Fig. S1).
Functional analysis of the transcriptional response of bMDM to M. bovis
infection. Each list of differentially expressed genes was interrogated using the online
Database for Annotation, Visualization, and Integrated Discovery (DAVID) (29, 30) for
functional annotation analysis. The ENSEMBL gene identiﬁers were used to identify
overrepresented Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways. Overall there was considerable similarity in the overrepre-
sented terms for infection with each M. bovis strain. Table 1 summarizes the overrep-
resented KEGG pathways at each time point postinfection. Throughout the time course
there was a considerable cytokine and chemokine response and evidence of the
activation of pathogen-sensing pathways, e.g., Toll-like receptor (TLR), NOD-like recep-
tor, RIG-I-like, and cytosolic DNA sensing pathways. In addition, there was evidence of
the activation of intracellular signaling pathways, with the overrepresentation of genes
associated with the Jak-STAT and mitogen-activated protein kinase (MAPK) signaling
pathways.
Apoptosis was overrepresented at 2 hpi and 6 hpi in response to both M. bovis
strains. However, the p53 signaling pathway, which is also involved in cell death, was
only overrepresented in the AF2122_6h gene list. Eleven genes associated with this
KEGG pathway were present in this gene list, including caspase 3 (CASP3), Fas, Mdm2,
p53 E3 ubiquitin protein ligase homolog (MDM2), MDM4, sestrin 1 (SESN1), and SESN3.
However, only 3 of these 11 genes, CD82, CASP8, and SESN1, were present in the
G18_6h gene list. This suggests that there are differences in host cell survival associated
with each M. bovis strain. Fc gamma R-mediated phagocytosis was only identiﬁed as an
overrepresented pathway in the G18_6h gene list, with 12 genes representing this
pathway in the gene list. However, nine of these genes were present in the AF2122_6h
gene list, suggesting that this pathway is activated in response to both infections.
The greatest number of differences in overrepresented pathways was observed at
48 hpi. The extracellular matrix (ECM)-receptor interaction pathway was overrepre-
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sented in the AF2122_48h gene list. Nine genes associated with this pathway were
present in this list, while only three of these were present in the G18_48h gene list.
Complement and coagulation cascades were overrepresented in the gene lists for G18
at 24 hpi and 48 hpi. However, many of the genes associated with this pathway were
differentially expressed at the same time points in response to AF2122. Although there
was not an M. bovis strain-speciﬁc effect, these complement and coagulation cascade-
associated genes were only differentially expressed at the later time points and
therefore represent a later response.
At 48 hpi the pathogen-sensing pathways cytosolic DNA sensing and RIG-I-like
receptor signaling were still overrepresented in the response to G18 but not AF2122
(Table 1). Several of the genes associated with these pathways are type I interferon (IFN)
TABLE 1 KEGG pathways overrepresented in the differentially expressed gene lists highlight similarities and differences in response of
bMDM to infection with M. bovis strainsa
Common KEGG pathway
Strain-speciﬁc pathway
AF2122 G18
2 h
NOD-like receptor signaling pathway CAMs B cell receptor signaling pathway
Cytokine-cytokine receptor interaction MAPK signaling pathway
Toll-like receptor signaling pathway
Chemokine signaling pathway
RIG-I-like receptor signaling pathway
Jak-STAT signaling pathway
T cell receptor signaling pathway
Cytosolic DNA-sensing pathway
Apoptosis
Hematopoietic cell lineage
Natural killer cell-mediated cytotoxicity
Adipocytokine signaling pathway
6 h
Cytokine-cytokine receptor interaction p53 signaling pathway Fc gamma R-mediated phagocytosis
NOD-like receptor signaling pathway
Chemokine signaling pathway
Toll-like receptor signaling pathway
Jak-STAT signaling pathway
RIG-I-like receptor signaling pathway
Apoptosis
B cell receptor signaling pathway
Adipocytokine signaling pathway
Cytosolic DNA-sensing pathway
T cell receptor signaling pathway
Hematopoietic cell lineage
Natural killer cell-mediated cytotoxicity
CAMs
MAPK signaling pathway
Fc epsilon RI signaling pathway
Leukocyte transendothelial migration
24 h
Cytokine-cytokine receptor interaction Complement and coagulation cascades
Chemokine signaling pathway
Cytosolic DNA-sensing pathway
NOD-like receptor signaling pathway
Toll-like receptor signaling pathway
Hematopoietic cell lineage
48 h
Cytokine-cytokine receptor interaction ECM-receptor interaction Cytosolic DNA-sensing pathway
NOD-like receptor signaling pathway Toll-like receptor signaling pathway
Hematopoietic cell lineage RIG-I-like receptor signaling pathway
Chemokine signaling pathway Complement and coagulation cascades
CAMs
aOverrepresented KEGG pathways were identiﬁed using the online Database for Annotation, Visualization and Integrated Discovery (DAVID) using a cutoff P value of
0.05. CAMs, cell adhesion molecules.
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response genes, and a large number of type I IFN response genes were present in the
differentially expressed gene lists. Of 280 genes induced by IFN- stimulation of
primary murine bone marrow-derived M (31), 33.9% were present in the gene lists
generated from the RNA-Seq data (Table S1). Furthermore, there was a greater number
of type I IFN response genes present in the G18_48h gene list than in AF2122_48h, e.g.,
myxovirus (inﬂuenza virus) resistance 1 (MX1), which was upregulated 3.1-fold in
response to G18 at 48 hpi but not signiﬁcantly differentially expressed in response to
AF2122 at this time point. Furthermore, other type I IFN response genes present in both
the AF2122_48 and G18_48 gene lists were upregulated to a higher degree in response
to G18 than AF2122 at this time point, e.g., ISG15 ubiquitin-like modiﬁer (ISG15), which
was upregulated 6.6- and 2.5-fold in response to G18 and AF2122, respectively.
However, the reverse pattern was observed at earlier time points, with a greater
number of type I IFN response genes being differentially expressed in response to
AF2122 than G18, e.g., MX1, which was upregulated 3.3- and 3.8-fold in response to
AF2122 at 6 hpi and 24 hpi, respectively, but not signiﬁcantly differentially expressed
in response to G18 at these time points (Data Set S1). In addition, other IFN response
genes were present in both AF2122 and G18 gene lists at 6 hpi and 24 hpi but were
expressed at higher levels during infection with AF2122 than G18, e.g., radical
S-adenosyl methionine domain containing 2 (RSAD2), which was upregulated 17.4- and
19.3-fold at 6 h and 24 h after AF2122 infection, respectively, but only upregulated 3.0-
and 2.3-fold after 6 h and 24 h infection with G18, respectively. In contrast, at 48 hpi
RSAD2 was upregulated 2.9- and 9.2-fold in response to AF2122 and G18, respectively.
These results suggest that there is a temporal difference in the type I IFN responses of
bMDM to infection with different M. bovis strains.
Validation of the RNA-Seq data. The expression of 19 genes was investigated by
reverse transcription (RT)-qPCR in a different set of samples derived from bMDM
generated from a different cohort of animals to conﬁrm the transcriptional response of
bMDM to infection with the M. bovis strains. The time course was extended to 72 h to
allow further investigation of the divergence in response at the later time points
observed in the analysis of the RNA-Seq data. Four genes were chosen for the RT-qPCR
analysis, which represented the p53 pathway, three of which, CASP3, FAS, and MDM2,
were differentially expressed in response to AF2122 6 hpi. In addition, the expression
of the transcription factor tumor protein 53 (TP53), also known as p53, was measured.
The timing of the type I IFN response appeared to differ between AF2122 and G18
infection of bMDM. To investigate this response, the expression of six genes, chemokine
(C-X-C motif) ligand 10 (CXCL10), interferon-induced protein with tetratricopeptide
repeats 1 (IFIT1), MX1, ISG15, 2=-5=-oligoadenylate synthetase 1, 40/46kDa (OAS1Y), and
RSAD2, was measured. Furthermore, the expression of the type I IFNs, IFNB1, IFNB3, IL-6,
and IFNA, was investigated. Many genes induced by type I IFNs are also regulated by
IFN-, the type II IFN, e.g., CXCL10 and ISG15 (31). Therefore, the expression of IFNG and
one of its target genes, indoleamine 2,3-dioxygenase 1 (IDO1), was investigated. Finally,
the expression of the cytokines IL1B, IL-10, and tumor necrosis factor (TNF) was
quantiﬁed.
p53 pathway. At the earlier time points only CASP3 and FAS were differentially
expressed compared with the uninfected controls, and this was observed in response
to G18 and not AF2122 (Table 2), which was in contrast to the RNA-Seq data. At 24 hpi
and 48 hpi all four genes, CASP3, FAS, MDM2, and TP53, were signiﬁcantly upregulated
in response to infection with both M. bovis strains compared to the uninfected control
(Table 2, asterisks). However, at 48 hpi and 72 hpi there were signiﬁcant differences in
the expression of all four genes associated with the M. bovis strain (Table 2, daggers),
with greater expression in response to AF2122 infection than G18 infection. Therefore,
there was a strain-associated difference in the expression of p53 pathway-associated
genes, conﬁrming the signiﬁcance of this pathway identiﬁed in the RNA-Seq data
analysis. However, the strain-speciﬁc differential expression of TP53 was only observed
72 hpi, later than the differences observed in CASP3 and MDM2 expression. This
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TABLE 2 Summary of RT-qPCR results quantifying the expression of genes during M. bovis infection of bMDMa
Gene M. bovis strain
Strain effect
(P value)
Result by time postinfection
2 h 6 h 24 h 48 h 72 h
TP53 AF2122 NS 0.9 0.1 0.9 0.1 1.4 0.1* 1.4 0.1* 1.9 0.2*†
G18 0.9 0.1 0.9 0.1 1.9 0.1* 1.6 0.1* 1.2 0.3
CASP3 AF2122 0.001 0.8 0.1 1.0 0.2 4.2 1.6* 6.1 1.4*† 11.6 2.7*†
G18 0.7 0.1* 0.9 0.1 3.4 0.8* 3.8 0.6* 3.5 1.0*
FAS AF2122 NS 0.8 0.1 3.6 1.0 4.5 0.5* 4.8 0.7* 9.6 1.4*†
G18 0.9 0.1 4.2 0.7* 3.7 0.4* 3.1 0.3* 4.1 1.1
MDM2 AF2122 0.001 1.1 0.1 1.2 0.1 2.6 0.2* 4.3 0.8*† 5.7 0.8*†
G18 1.1 0.1 1.1 0.1 2.5 0.1* 3.1 0.5* 3.1 0.5*
IFNB1 AF2122 0.021 1.3 0.7 1.3 0.4 1.4 0.4 3.2 0.9 6.0 1.7†
G18 0.7 0.2 1.6 0.6 1.3 0.4 1.9 0.8 2.0 0.4
IL-6 AF2122 NS 5.3 1.3* 47.9 19.8* 592.5 202.5* 647.8 262.3* 1,916.7 918.9*
G18 7.4 2.1* 41.6 17.5* 346.7 109.1* 470.1 208.1* 876.5 339.2*
IFNB3 AF2122 NS 2.8 1.3 2.2 1.2 5.0 3.1 4.8 1.1* 17.2 7.5†
G18 3.0 1.5 2.2 0.7 2.4 0.6 3.4 1.4 2.9 1.0
IFNA AF2122 0.036 2.2 1.8 1.0 0.4 1.6 0.3 5.5 2.1† 9.2 3.9†
G18 1.6 0.9 1.5 0.8 1.6 0.7 1.6 0.6 2.4 1.1
CXCL10 AF2122 NS 6.5 5.6 16.0 11.7 69.8 33.1* 5.5 1.1* 4.2 1.8
G18 4.9 4.0 9.6 7.0 70.0 48.3* 14.0 6.0 21.1 16.1
IFIT1 AF2122 NS 0.7 0.2 1.5 0.6 5.9 2.2 17.9 9.6 22.9 10.5
G18 0.8 0.2 1.3 0.5 3.6 0.7 3.6 0.7* 12.8 7.8
ISG15 AF2122 0.031 1.0 0.2 2.1 1.0 31.5 7.5* 47.0 21.3*† 39.5 19.1*
G18 1.1 0.2 2.0 1.2 23.9 7.6* 6.3 1.7* 21.1 9.7*
MX1 AF2122 NS 0.9 0.3 0.9 0.2 5.1 1.7* 9.2 5.4† 7.6 4.2
G18 1.0 0.3 1.0 0.4 3.2 0.7 1.5 0.2 4.3 2.9
OAS1Y AF2122 NS 0.9 0.3 0.9 0.2 4.0 0.7* 5.6 2.3† 5.7 2.4
G18 1.0 0.2 0.9 0.2 3.0 0.5* 1.4 0.3 2.5 1.0
RSAD2 AF2122 0.008 0.9 0.2 5.3 2.4 88.2 41.5* 332.8 255.8*† 174.6 126.7*
G18 0.9 0.2 3.9 2.3 31.5 5.8* 16.3 2.9* 85.1 65.9*
IFNG AF2122 0.001 3.7 3.0 17.9 12.7 227.8 102.4*† 156.5 56.7*† 119.6 40.4*
G18 1.8 1.2 11.2 8.7 87.1 52.7* 67.9 26.9* 111.4 41.9*
IDO1 AF2122 0.018 2.5 1.5 5.0 2.9 2,363.4 1,032.4*† 2,272.1 837.0*† 523.9 174.0*
G18 2.0 1.1 4.1 2.1 1,006.5 523.5* 871.3 462.5* 1,025.2 537.1*
IL1B AF2122 NS 20.4 7.3* 158.9 53.0* 6,615.2 2,246.9* 4,586.5 1,781.4*† 2,579.3 1,024.0*
G18 25.0 8.5* 148.0 41.5* 2,856.4 5,86.2* 1,751.9 515.0* 2,188.3 924.1*
IL-10 AF2122 0.001 5.9 1.3* 8.2 4.4 4.1 1.0* 1.0 0.4† 0.4 0.1*†
G18 6.5 1.1* 9.3 4.9* 9.1 1.5* 4.6 0.8* 2.0 0.6
TNF AF2122 NS 38.0 18.1* 122.5 34.2* 286.2 55.0* 101.8 22.7*† 82.6 28.7*
G18 43.7 15.7* 151.3 32.0* 122.3 23.1* 69.8 16.0* 93.4 26.4*
aThe results are expressed as the average fold change in mRNA levels in bMDM during infection with M. bovis strains AF2122 and G18 compared to levels of the
uninfected controls  standard errors. An asterisk indicates when the mean fold change values were signiﬁcantly different from values for resting cells by t test
corrected for multiple testing (Benjamini-Hochberg) (P  0.05). The effect of M. bovis strain is shown (repeated-measures analysis by GLM with subsequent Fisher’s
test). NS denotes that there was no signiﬁcant strain-speciﬁc difference in mRNA levels by GLM. Daggers denote time points where there was a signiﬁcant strain-
speciﬁc difference in the average mean fold change identiﬁed by the time point and strain interaction (GLM with subsequent Fisher’s test).
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suggests that the transcription factor TP53 does not regulate the expression of these
genes and that other pathways must be involved.
Analysis of bMDM survival during M. bovis infection. AF2122 infection induced
higher expression of p53-signaling pathway-associated genes. These genes are also
involved in other pathways associated with cell death, e.g., apoptosis. Analysis by light
microscopy revealed that bMDM infected with G18 appeared healthier than those
infected with AF2122. G18-infected bMDM remained adherent and maintained their
morphology, while a greater proportion of those infected with AF2122 detached (data
not shown). To investigate if there were differences in cell survival in bMDM infected
with the two M. bovis strains, cells were stained with a viability stain 48 hpi, when the
altered morphology was observed and the strain-speciﬁc differential expression of p53
pathway-associated genes became apparent. bMDM treated with 1% paraformalde-
hyde (PFA) showed considerable staining with the viability dye (Fig. 3A). However, there
was no difference in viability staining of G18-infected bMDM and uninfected bMDM
(Fig. 3A and B). In contrast, there was a shift in viability staining in cells infected with
AF2122, an example of which is shown in Fig. 3A. Although the viability dye staining
was not as strong as that observed with the positive control, the mean ﬂuorescence
intensity (MFI) values were signiﬁcantly higher in cells infected with AF2122 than G18
and uninfected bMDM (Fig. 3B). There was no signiﬁcant difference in MFI of uninfected
and G18-infected bMDM. Zombie stains bind to primary amine groups of proteins and
are excluded from live cells. The shift in viability staining suggests that by 48 hpi bMDM
infected with AF2122 are dying, with an impaired ability to exclude the viability dye,
while those infected with G18 remain healthier, consistent with the data from the
transcriptional analysis.
The mechanism of bMDM cell death was investigated by quantifying the number of
apoptotic and necrotic bMDM 48 hpi by analyzing the presence of phosphatidylserine
on the cell surface and the loss of plasma membrane integrity, respectively. Flow
cytometry results for one representative animal are shown in Fig. S2. AF2122 infection
did not increase the number of necrotic bMDM but did increase the number of
apoptotic bMDM compared with uninfected bMDM and those infected with G18 (Fig.
3C). Furthermore, there were signiﬁcantly more bMDM simultaneously exhibiting mark-
ers of apoptosis and necrosis with AF2122 infection than with either G18 infection or
uninfected controls (Fig. 3C). In contrast, G18 infection did not affect the proportion of
healthy bMDM, with no signiﬁcant difference in the number of apoptotic or necrotic
cells compared to uninfected bMDM (Fig. 3C), providing further evidence that the G18
M. bovis strain induces less cytotoxicity in bMDM than AF2122.
IFN response. The type I IFN response differed across the infection time course in
the RNA-Seq data, with a greater response observed to AF2122 infection than G18
infection at earlier time points, which was reversed at 48 hpi. However, signiﬁcant
upregulation of expression of the six type I IFN-regulated genes investigated, CXCL10,
IFIT1, ISG15, MX1, OAS1Y, and RSAD2, was only observed from 24 hpi (Table 2) in the
repeat experiments. At 24 hpi, when only RSAD2 was found to be differentially
expressed by G18 infection by analysis of the RNA-Seq data (Data Set S1), four genes,
OAS1Y, CXCL10, ISG15, and RSAD2, were upregulated in response to AF2122 and G18
(Table 2, asterisks), and there was no strain-speciﬁc difference in expression in any of
the six investigated genes. At 48 hpi, when the RNA-Seq data analysis revealed a
greater type I IFN response in bMDM infected with G18 than with AF2122, RT-qPCR
analysis revealed strain-speciﬁc differential expression of ISG15, MX1, OAS1Y, and
RSAD2, with signiﬁcantly greater responses to AF2122 than G18 (Table 2, daggers), e.g.,
RSAD2 mRNA levels exhibited 332.8-  255.8-fold upregulation compared to the
uninfected control in response to AF2122 infection but only 16.3-  2.9-fold upregu-
lation in response to G18 infection. However, there were no signiﬁcant differences in
expression of the investigated type I IFN response genes at 72 hpi, largely due to the
increasing levels of expression in response to G18. Therefore, although there was a shift
in the timing of the type I IFN response revealed by the RT-qPCR analysis, there was
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evidence of a difference in the response to different M. bovis strains, with a greater type
I IFN response to AF2122 at 48 hpi and the suggestion of the beginning of a switch at
72 hpi, which may have become more apparent if the time course had been extended
further.
FIG 3 M. bovis strains differ in their effect on bMDM survival. The viability of bMDM was investigated 48
hpi by two methods. First, bMDM were stained with Zombie NIR cell viability dye. (A) Example of a ﬂow
cytometry histogram illustrating the shift in staining of bMDM infected with AF2122 (green line)
compared to uninfected bMDM (gray line) and those infected with G18 (blue line). The red line illustrates
staining of bMDM treated for 30 min with 1% PFA. (B) Histogram illustrating the average mean
ﬂuorescence intensities (MFI) of uninfected bMDM (NC) and bMDM infected with M. bovis strains. Error
bars denote the standard errors from ﬁve biological replicates. The statistical signiﬁcance of the MFI
differences was investigated by t test, and the resulting P values are indicated in the graph. n.s., not
signiﬁcant. (C) The proportion of bMDM dying by apoptosis and necrosis was investigated. The histogram
illustrates the average percentage of bMDM exhibiting markers of apoptosis and necrosis in uninfected
cells (gray bars), AF2122-infected cells (green bars), and G18-infected cells (blue bars). Error bars denote
the standard errors from ﬁve biological replicates. An asterisk denotes that there was a statistically
signiﬁcant difference in the number of bMDM exhibiting that phenotype and that of uninfected bMDM
by GLM and subsequent Fisher’s test (P  0.05).
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The expression of the type I IFN genes was also investigated. None of these genes
were identiﬁed as being differentially expressed in the RNA-Seq data; however, the
duplication of IFNA and other type I IFN gene family members in the bovine genome
(32) makes alignment of short RNA-Seq reads difﬁcult, which may mean that these
genes were missed from the analysis. IFNB1 and IFNB3 were only signiﬁcantly differ-
entially expressed at 72 hpi, with signiﬁcantly higher expression in response to AF2122
than G18. IL-6, also known as IFNB2, was upregulated at all time points compared to the
uninfected controls, without any strain-speciﬁc difference in expression. There are 13
IFNA genes, sharing a high degree of sequence homology, located in the bovine
genome (32); therefore, generic primers were designed for IFNA, which revealed
signiﬁcantly higher expression of IFNA in response to AF2122 infection than to G18
infection at 48 hpi and 72 hpi. Therefore, the differential expression of one or more of
the IFN- family members may account for the observed strain-speciﬁc differential
expression of the investigated type I IFN response genes at 48 hpi.
The type II IFN gene IFNG was also investigated due to overlap in regulation of genes
by type I and type II IFNs. In contrast to the type I IFNs, IFNG was differentially expressed
from 24 hpi in response to infection with both M. bovis strains and exhibited strain-
speciﬁc differential expression at 24 hpi and 48 hpi, with greater expression in response
to AF2122 infection than G18 infection (Table 2 and Fig. 4A). This difference was also
seen at the protein level (Fig. 4B), with signiﬁcantly higher release of IFN- from bMDM
infected with AF2122 than G18 (P  0.001). Furthermore, expression of IDO1, which is
stimulated by IFN-, also exhibited M. bovis strain-speciﬁc differential expression at 24
hpi and 48 hpi (Table 2). Therefore, the strain-speciﬁc differential expression of IFN-
may partly explain the differential expression of some type I IFN response genes which
are also regulated by IFN-, e.g., ISG15.
Expression of proinﬂammatory cytokines IL-1 and TNF and the anti-inﬂammatory
cytokine IL-10. IL-1 mRNA levels were upregulated throughout the time course in
response to infection with bothM. bovis strains (Table 2 and Fig. 5A). However, maximal
IL-1 mRNA levels were observed at 24 hpi, which was later than that seen in the
RNA-Seq data. The measured IL-1 mRNA levels over the whole time course were not
signiﬁcantly different in response to AF2122 or G18 (P  0.071), but there was a
statistically signiﬁcant strain-speciﬁc difference in IL-1 expression at 48 hpi. The
production and release of mature IL-1 protein were investigated by enzyme-linked
immunosorbent assay (ELISA). IL-1 protein was released in response to infection with
both M. bovis strains, suggesting that inﬂammasomes, multiprotein complexes that
process the immature pro-IL-1 into the active form, are activated by infection.
However, due to the high degree of variability in the amount of IL-1 released by
bMDM from different animals in response to G18 infection, the amount produced was
not statistically signiﬁcantly different from that of uninfected cells. Moreover, signiﬁ-
cantly more IL-1 protein was released in response to AF2122 infection than G18
infection from 24 hpi onwards (P  0.001) (Fig. 5B). At 24 hpi, over 11 times more IL-1
protein was released in response to AF2122 infection than G18 infection (P 0.05) (Fig.
5B). In contrast, the average fold change in IL-1 mRNA level in response to AF2122
infection was 2.1-fold higher than that induced by G18 infection at 24 hpi, which was
not a signiﬁcant difference (Fig. 5A). Therefore, the modest difference in IL-1 mRNA
levels observed by 24 hpi cannot account for the great divergence in IL-1 protein
being produced in response to different M. bovis strains. The detection of a greater
amount of IL-1 protein in the supernatants of AF2122-infected bMDM may relate to
the release of pro-IL-1 by the higher proportion of dying cells during AF2122 infection.
Alternatively, this disparity in mRNA and protein levels suggests that inﬂammasomes
were activated earlier and to a greater extent in response to AF2122 than G18 infection.
Inﬂammasome activity during M. bovis infection was investigated by measuring
CASP1 activation. Although the shift in ﬂuorescence was relatively minor, probably due
to the signal being masked by the highly autoﬂuorescent nature of bMDM, signiﬁcantly
more activated CASP1 was detected in bMDM infected for 24 h with AF2122 than G18
(Fig. 5C and D). However, CASP1 activation during G18 infection was not statistically
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signiﬁcantly higher than that observed in uninfected bMDM due to the level of
variation in the biological replicates, as with the IL-1 ELISA results. To conﬁrm
inﬂammasome activity in M. bovis-infected cells, IL-1 protein levels in cell lysates and
supernatants were investigated by Western blotting. Pro-IL-1 protein levels were
consistently greater in AF2122-infected bMDM than in G18-infected bMDM (Fig. 5E),
conﬁrming the IL-1 mRNA results (Fig. 5A). Mature IL-1 was not detected in cell
lysates; however, both pro-IL-1 and mature IL-1 were detected in cell supernatants
(Fig. 5F). The antibodies used in the IL-1 ELISA were found to detect both mature and
pro-IL-1 (data not shown), and therefore the presence of both proteins contributes to
the ELISA result (Fig. 5B). Pro-IL-1 is presumably released by cells dying in response to
AF2122 infection and accounts for the greater proportion of IL-1 present in the
supernatants. However, mature IL-1 was consistently detected in supernatants from
AF2122-infected bMDM, while little or no mature IL-1 was detected in supernatants
from G18-infected bMDM (Fig. 5F), even though pro-IL-1 is produced by these cells
(Fig. 5E). These results provide further evidence thatM. bovis strains differ in their ability
to stimulate host cell inﬂammasomes.
As with IL-1, mRNA levels of the proinﬂammatory cytokine TNF were signiﬁcantly
upregulated compared to those of the uninfected controls throughout both infection
FIG 4 IFN- production by bMDM varies in response to infection with different M. bovis strains. (A and
B) Average IFN-mRNA fold change (A) and IFN- protein released (B) from bMDM infected with AF2122
(green squares) and G18 (blue triangles). Error bars denote the standard errors from ﬁve biological
replicates. An asterisk denotes that the expression at that time point is statistically signiﬁcantly different
from the level of IFN- in uninfected bMDM. Black circles denote time points where there is a statistically
signiﬁcant difference in IFN- mRNA or protein levels in response to the two different M. bovis strains.
The statistical signiﬁcance of M. bovis strain over the whole time course is indicated on each graph.
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time courses (Table 2 and Fig. 6A). TNF mRNA levels were upregulated to similar extents
in response to both M. bovis strains, except at 24 hpi, when there was, on average, over
two times higher expression in response to AF2122 than G18. The greater production
of TNF in response to AF2122 infection was also observed at the protein level (Fig. 6B),
which was statistically signiﬁcantly different from that produced in response to G18
infection over the 72-h time course (P  0.001).
IL-10 mRNA levels were elevated at 2 hpi and 6 hpi in response to both M. bovis
strains in the RNA-Seq experiment. However, in the validation samples, IL-10 mRNA
levels were elevated over the whole 72-h infection period, with maximal expression
observed at 6 to 24 hpi (Fig. 6C). There was no signiﬁcant difference in IL-10 mRNA
levels induced by AF2122 and G18 infection up to 24 h, but from 6 h onwards IL-10
mRNA levels returned to baseline levels more rapidly following AF2122 infection than
G18, resulting in signiﬁcantly higher levels of IL-10 mRNA at 48 hpi and 72 hpi in bMDM
infected with G18. This pattern was also observed at the protein level, although the
difference between M. bovis strains did not reach statistical signiﬁcance (Fig. 6D).
DISCUSSION
Pathogenic mycobacteria, especially M. tuberculosis and M. bovis, are responsible for
arguably the most important bacterial diseases of humans and domestic animals
occurring around the globe. These mycobacteria invade alveolar M, where they adapt
the host cell to form a niche where they can survive, protected from the host’s immune
response. Previously, variation in the response of infected M to different mycobacteria
has been reported, although most of this work has compared virulent and highly
attenuated strains of mycobacteria, e.g., the vaccine strain of M. bovis Bacille Calmette-
FIG 5 IL-1 production varies in response to different M. bovis strains. (A and B) Average IL-1B mRNA fold change (A) and average IL-1 protein release (B) by
bMDM infected with AF2122 (green squares) and G18 (blue triangles). Error bars denote the standard errors from ﬁve biological replicates. An asterisk denotes
that the expression at that time point is statistically signiﬁcantly different from the level of that transcript or protein in uninfected bMDM. Black circles denote
time points where there is a statistically signiﬁcant difference in IL-1 mRNA or protein levels in response to the two different M. bovis strains. The statistical
signiﬁcance of M. bovis strain over the whole time course is indicated on each graph. (C) Example of a ﬂow cytometry histogram illustrating the shift in
FAM-FLICA staining, indicative of CASP1 activation, of bMDM infected with AF2122 (green line) and G18 (blue line) compared to uninfected bMDM (gray line).
(D) Histogram illustrating the average mean ﬂuorescence intensities (MFI) of uninfected bMDM (NC) and bMDM infected with M. bovis strains. Error bars denote
the standard errors from four biological replicates. Two asterisks denote that there was a statistically signiﬁcant difference in CASP1 activity compared to that
of uninfected bMDM by GLM and subsequent Fisher’s test (P  0.001). (E) Western blot illustrating pro-IL-1 protein levels in bMDM cell lysates 24 h after M.
bovis infection. U denotes uninfected, and A and G denote bMDM infected with AF2122 and G18, respectively. bMDM 1 and 2 relate to bMDM isolated from
different biological replicates. -Actin was included as a loading control. (F) Western blot illustrating pro-IL-1 and mature IL-1 protein present in bMDM
supernatants collected 48 h after M. bovis infection. Numbers relate to bMDM isolated from different biological replicates.
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Guerin (BCG) (23, 33). We wished to investigate if early events during M infection
would vary with different M. bovis ﬁeld strains isolated from infected cattle from the
United Kingdom (20, 27). Therefore, we compared various aspects of the early inter-
action of bMDM with two extant strains of M. bovis, G18 and AF2122, which are
genetically relatively divergent among the UK M. bovis population. AF2122 reached
higher intracellular numbers during the ﬁrst 72 h following in vitro infection of bMDM
than G18 and had more profound effects on the host M, inducing more cell death and
a greater transcriptional response.
The survival and replication of M. bovis during bMDM infection were measured by
two methods: qPCR quantiﬁcation of GCN and conventional CFU counts. The initial
uptake of the two M. bovis strains was similar, but during the ﬁrst 24 h the number of
viable G18 organisms was static, while AF2122 numbers increased. However, G18 was
replicating during this apparent hiatus, as revealed by the increasing GCN, although at
a lower rate than AF2122. Therefore, the dynamics of M. bovis growth and survival were
only revealed by combining simultaneous quantiﬁcation of CFU and GCN, illustrating
that G18 was able to replicate but the bMDM were initially killing the mycobacteria at
the same rate as G18 replication. However, the ability of bMDM to constrain G18
numbers was lost after 24 h. Overall the results show that AF2122 has the ability to
replicate at a higher rate than G18 in these bMDM and is better able to evade M
mycobactericidal activity.
FIG 6 TNF and IL-10 production varies in response to different M. bovis strains. (A to D) Average TNF (A) and IL-10 (C) mRNA fold change and
average TNF (B) and IL-10 (D) protein release by bMDM infected with AF2122 (green squares) and G18 (blue triangles). Error bars denote the
standard errors from ﬁve biological replicates. An asterisk denotes that the expression at that time point is statistically signiﬁcantly different from
the level of that transcript or protein in uninfected bMDM. Black circles denote time points where there is a statistically signiﬁcant difference in
mRNA or protein levels in response to the two different M. bovis strains. The statistical signiﬁcance of M. bovis strain over the whole time course
is indicated on each graph.
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Analysis of the RNA-Seq data suggested that the major transcriptional response of
bMDM to M. bovis infection occurred at 6 hpi, within this early phase of infection when
the dramatic difference in survival and replication of the two M. bovis strains was
observed. Overall the transcriptional responses to infection with the twoM. bovis strains
were very similar, but there were differences in the intensity of the response with
respect to the number of genes and changes in the level of expression measured at this
early time point. Therefore, we hypothesized that these differences could account for
the variation in AF2122 and G18 growth rates during the ﬁrst 24 h of infection.
However, the subsequent validation work, using bMDM generated in the same way as
those used in the intracellular growth assay, revealed a temporal shift in the response
of all the investigated genes. M. bovis strain-speciﬁc differential expression was ﬁrst
observed 24 hpi, when bMDM had lost that ability to control G18 growth, and the
greatest transcriptional response occurred between 24 and 48 hpi, similar to that
observed in a recent study investigating the response of bovine alveolar M to AF2122
infection (34). However, the RNA-Seq and subsequent validation work were in agree-
ment that AF2122 induces a much greater transcriptional response in bMDM than G18.
This conclusion is reinforced when it is considered that, although temporally shifted,
this greater response was observed in bMDM generated by similar, but distinct,
methods from cells isolated from unrelated animals, using different batches of myco-
bacteria, and using different infection methodologies.
Analysis of the RNA-Seq data identiﬁed differential regulation of genes associated
with the p53-signaling pathway during infection with the two M. bovis strains. Subse-
quent analysis conﬁrmed that several genes in this pathway, which are also involved in
the regulation of cell death, e.g., CASP3 and MDM2, were induced at signiﬁcantly higher
levels in response to AF2122 infection than G18, which correlated with an increase in
the death of AF2122-infected bMDM. Early apoptosis of M infected with avirulent
mycobacteria has previously been reported (35). However, the cell death induced by
AF2122 had characteristics of apoptosis and necrosis, with detectable phosphatidyl-
serine on the cell surface and loss of membrane integrity, respectively. This type of cell
death has previously been described in association with high intracellular mycobacte-
rial loads (36–39). It is unclear if this is a distinct form of necrosis or if apoptotic cells
rapidly progress to secondary necrosis. The fact that AF2122 induces an increase in
apoptotic cells as well as bMDM with markers of apoptosis and necrosis suggests that
the latter is the case. However, the apoptosis is atypical, being independent of caspases
and cathepsins (38). It was originally thought that mycobacteria remained within the
modiﬁed phagosome in M, but it is now known that some mycobacteria can escape
into the cytoplasm, and this is a major trigger for necrosis of the infected M (39–41).
Apoptosis of infected M results in mycobacteria being trapped within apoptotic
bodies, and when these are engulfed by uninfected M the mycobacteria are unable
to prevent lysosome fusion, as they do during primary infection, which leads to their
death (42). In contrast, necrosis promotes bacterial survival and proliferation, allowing
the release of mycobacteria into the extracellular environment, which are then able to
successfully infect naive M.
The presence of more mycobacteria, or at least more mycobacterial components, in
the cytoplasm of AF2122-infected bMDM is supported by three additional observations.
First, a greater type I IFN response was observed during AF2122 infection, with higher
expression of IFN- and IFN- proteins, along with the downstream type I IFN response
genes, e.g., MX1 and RSAD2. Type I IFNs are induced in response to stimulation of
pathogen recognition receptors, many of which are cytosolic, e.g., NOD2, cGAS, and
RIG-1 (43). The ESX-1 secretion system of M. tuberculosis, which enables effector
proteins to be secreted into the host cell cytoplasm, has been shown to be important
in the induction of the type I IFN response (44). Second, the initial levels of upregulation
of TNF produced in response to AF2122 and G18 infection were similar, but at 24 hpi
there was a spike in production in AF2122-infected cells. The activity of the intracellular
receptor NOD2 is responsible for most TNF produced by human MDM in response to
M. tuberculosis and BCG (45). The presence of AF2122 or AF2122 components in the
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cytoplasm may explain the elevation in TNF production. Third, there was greater
activation of inﬂammasomes during AF2122 infection than G18 infection, resulting in
the production and release of a greater amount of mature, active IL-1 protein. IL-1
protein produced by human MDM in response to M. tuberculosis infection has been
shown to be proportional to the infection dose (38). Therefore, the greater mycobac-
terial burden of AF2122 in bMDM may account for many aspects of the observed
differences in the M. bovis-bMDM interaction observed in this study. The AF2122
burden reaches a threshold that induces translocation into the bMDM cytoplasm, which
in turn induces bMDM cell death and activation of cytoplasmic receptors, leading to
greater inﬂammasome activation and type I IFN responses. These in turn may act by
feedback loops to alter the bMDM transcriptional response.
The mechanisms underlying the ability of AF2122 to replicate at higher rates in
bMDM than G18, associated with faster replication and less mycobacterial death, are
currently unknown. One mechanism may be that AF2122 regulates the production of
nitric oxide by bMDM, which has been shown to limit M. bovis growth in bMDM (46).
The G18 genome has not been sequenced to date, unlike that of AF2122 (15). A
comparison of the genome sequences and transcriptomes of several M. bovis strains
representing the major lineages circulating in Great Britain, including AF2122 and an
isolate similar to G18, identiﬁed strain-speciﬁc differential expression of over 50M. bovis
genes during the ﬁrst 24 h of alveolar M infection (47), which may inﬂuence early
events in the M. bovis-M interaction. However, the growth of these M. bovis strains in
alveolar M was not compared in this study. Comparison of the AF2122 and G18
genome sequences in conjunction with our knowledge of their growth and survival in
bMDM and the host transcriptional response may in the future help to elucidate the
mechanisms that promote AF2122 growth while restricting G18.
The comparison of the interaction between bMDM and the two M. bovis strains
described in this study revealed that they use different strategies during infection of
bMDM. AF2122 employs a hit-and-run approach, with rapid growth associated with a
profound effect on the biology of the infected bMDM, while G18 takes a more stealthy
approach, with slower mycobacterial growth and lower bMDM responses. Higher levels
of the anti-inﬂammatory cytokine IL-10 induced by G18 than AF2122 may play an
important role in the more silent infection of G18, which is currently being investigated
(K. Jensen and E. J. Glass, unpublished data). Unfortunately, a direct comparison of the
pathologies induced by theseM. bovis strains has not been made, and therefore it is not
known if these differences in host-pathogen interactions affect the development of
disease in cattle. Growth of M. bovis and M. tuberculosis in M has previously been
correlated with pathogenicity in mouse models (25, 48), which would imply that
AF2122 is more virulent than G18. This is supported by comparisons of the transcrip-
tional responses of virulent and attenuated M. bovis strains. Infection of alveolar M by
virulent M. bovis induced greater transcription of several chemokines, e.g., chemokine
(C-C motif) ligand 5 (CCL5) and chemokine (C-X-C motif) ligand 1 (CXCL1), than that
induced by an attenuated isogenic strain (23). Transcription of several of these chemo-
kines was greater in response to AF2122 than G18 infection. Furthermore, many genes
found to be more highly expressed in bMDM infected with virulent M. bovis than with
BCG (33) were upregulated to a greater extent during AF2122 infection than G18
infection. Conversely, many of the genes expressed at higher levels in BCG-infected
bMDM than those infected with virulent M. bovis were downregulated to a greater
degree by AF2122 infection than G18 infection. However, there are insufﬁcient data
available at present to assess whether the response of G18 is typical of UK M. bovis
strains and AF2122 is hyperstimulatory or if G18 is the outlier.
AF2122 and G18 are both considered virulent, having been isolated from tuberculin
skin test reactor cattle in southwest England and Northern Ireland, respectively. Phy-
logenetic analysis of M. bovis isolates has shown that the same major phylogenetic
lineage is present throughout the United Kingdom and Ireland and forms a linear
phylogeny with AF2122 at the terminal branch in a sublineage designated B (17).
AF2122 contains more unidirectional mutations than other M. bovis sublineages sam-
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pled, e.g., sublineage P represented by G18, which implies that the ancestors of AF2122
evolved more recently than those of G18. Challenge studies have shown that AF2122
is highly virulent, and an infection dose of less than 10 bacilli results in pathology in
50% of infected cattle, with the development of large granulomas, aggregates of
immune cells surrounding the infected M which are indicative of mycobacterial
infection (27, 28). On average, these granulomas occupy nearly two-thirds of the lymph
node where they establish (27). G18 was among the least virulent strains of M. bovis
found in Northern Ireland with respect to the proportion of infected animals with
visible granulomas (20). This may be related to the more silent infection of M by G18
seen in this study, involving slower replication of the mycobacteria and more limited
signaling by the infected M to attract other immune cells to form the granuloma.
Conversely, the greater transcriptional response induced by AF2122 may attract more
immune cells to the site of infection, which, along with greater necrosis and higher
mycobacterial numbers, might result in the increased foci of infected cells and the
development of larger granulomas.
It is interesting to postulate that the interaction of AF2122 and G18 with bovine M
and subsequent granuloma formation affect the transmissibility of these M. bovis
strains. It is possible that the rapid growth and dissemination of AF2122 lead to
suboptimal immune responses in vivo. AF2122 belongs to the SB0140 spoligotype,
which is the dominant genotype circulating in the United Kingdom. In contrast,
although still circulating in Northern Ireland, the prevalence of G18 is diminishing over
time, suggesting that it is relatively less transmissible than some other M. bovis strains.
However, there are currently insufﬁcient data available on variation in relative trans-
missibility among M. bovis genotypes to shed light on this hypothesis at this time (49).
In conclusion, the two investigated M. bovis strains appear to interact in signiﬁcantly
different ways with the host M in vitro. These differences may affect early events in the
development of the immune response and pathogenesis, which could in turn alter the
progression of the disease. Therefore, the potential relationship between M. bovis
genotype and the effect on pathogenesis and epidemiology warrants further investi-
gation.
MATERIALS AND METHODS
Animals. Peripheral blood mononuclear cells (PBMC) were isolated from female Holstein-Friesian
cattle maintained at the Agri-Food & Biosciences Institute (AFBI), Belfast, United Kingdom, and The Roslin
Institute, University of Edinburgh, Edinburgh, United Kingdom. The cattle were between 1 and 2 years
of age and originated from M. bovis- and Johne’s disease-free farms. All animals were clinically normal,
and all experimental protocols were authorized under the UK Animals (scientiﬁc procedures) Act, 1986,
and performed to Home Ofﬁce guidelines. In addition, The Roslin Institute’s Animal Welfare and Ethics
Committee (AWEC) and the AFBI Veterinary Sciences Division (VSD) Ethical Review Committee ensured
compliance with all relevant legislation and promote the adoption and development of the 3Rs
(replacement, reduction, and reﬁnement).
Bacterial strains and culture. Two genotypes ofM. bovis isolated in the United Kingdom, AF2122/97
(spoligotype SB0140, lineage B) (15, 17) and G18 (spoligotype SB0129, lineage P) (17, 20), were cloned
to single colonies prior to growth to mid-log phase in liquid Middlebrook 7H9 medium containing Tween
80 and supplemented with 10% albumin-dextrose-catalase (ADC). The mycobacteria then were har-
vested and prepared as single-cell suspensions by vortexing or using a combination of ﬁltration and
sonication before being frozen.
Macrophage culture and challenge. bMDM for the RNA-Seq analysis were prepared as follows.
Peripheral blood was collected from the jugular vein into sterile bags containing sodium heparin
(Fannin), and PBMC were separated by density gradient centrifugation using Ficoll-Paque plus (GE
Healthcare Life Sciences). The resulting PBMC were seeded at 3 106 cells/ml in 75-cm2 ﬂasks and grown
in M medium (RPMI 1640 medium [Invitrogen] supplemented with 15% fetal bovine serum [Lonza
Biologicals], 20 mM L-glutamine, nonessential amino acids [Invitrogen], 50 mM HEPES, and antibiotics/
antimycotics [Invitrogen]). After 2 to 3 h of culture at 37°C and 5% CO2, the nonadherent cells were
removed and the adherent cells cultured for 9 days in M medium. The M medium was replaced after
24 h and then after every 48 to 72 h. The bMDM were detached using cell dissociation solution
(Sigma-Aldrich) and replated on day 9. On approximately day 13, the bMDM were harvested as described
above and transferred to 25-cm2 ﬂasks, seeded at up to 3  105 cells/ﬂask, and cultured for a further 24
h before infection. Flow cytometry, using an anti-bovine CD14 antibody (MCA2678GA; Bio-Rad), con-
ﬁrmed that the M purity exceeded 95% (data not shown).
The bMDM used in all other experiments were derived from different cattle from those used for the
RNA-Seq samples and generated using a protocol similar to that described previously (50). In brief, PBMC
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were cultured in 75-cm2 ﬂasks for 2 h in RPMI 1640 medium without serum at 5  106 cells/ml, before
the medium was replaced with bMDM medium (RPMI 1640 supplemented with 20% fetal bovine serum
[FBS], 4 mM L-glutamine, and 50 M -mercaptoethanol) with 100 U/ml penicillin-streptomycin. The
bMDM medium was replaced on day 7. On day 11 the adherent cells were rigorously washed with
phosphate-buffered saline (PBS) and detached with TrypLE Express (Invitrogen). Flow cytometry, using a
mouse anti-human CD14 antibody directly conjugated with Alexa Fluor 647 (MCA1568A647T; Bio-Rad),
conﬁrmed that the bMDM purity exceeded 94% (data not shown). Puriﬁed bMDM were resuspended at
3  105 cells/ml in bMDM medium without penicillin-streptomycin, aliquoted into 12-well plates (1
ml/well), and cultured for 72 h before infection on day 14.
Frozen mycobacterial stocks were thawed and prepared in bMDMmedium. In all experiments, bMDM
derived from each biological replicate were simultaneously infected with one of the M. bovis strain at a
multiplicity of infection (MOI) of 5. Medium only was added to the uninfected controls. Flasks containing
bMDM for the RNA-Seq time course experiment were rocked every 15 min for 2 h, and the medium was
replaced 6 hpi. Plates containing infected bMDM for all other experiments were centrifuged at 300  g
for 5 min, and the medium was replaced 1 hpi.
RNA-Seq experiment. bMDM derived from six biological replicates were infected with the two
strains of M. bovis or left uninfected, and RNA was isolated at 2, 6, 24, and 48 hpi. The medium was
removed and the bMDM were lysed with 2.5 ml TRIzol reagent (Invitrogen) for 20 min to ensure
mycobacterial inactivation. RNA was extracted at the ARK-Genomics Facility by following the manufac-
turer’s instructions. The mRNA was puriﬁed and fractionated to generate fragments with a median size
of 180 to 210 nucleotides. These fragments were reverse transcribed using random primers to generate
cDNA libraries. The libraries were sequenced as multiplexes, four tagged samples per ﬂow cell lane, on
an Illumina Genome Analyzer IIx platform and sequenced using a paired-end protocol of 54 cycles,
resulting in 108 nucleotides being sequenced from each mRNA fragment. Quality control (QC) analysis
of the data revealed that over 95% of sequences had good quality scores over the entire 54 nucleotides
and, on average, six million reads were generated per sample. Furthermore, on average, 80% of
sequences mapped uniquely to the bovine genome.
RNA-Seq data analysis. After QC, the data were aligned to the bovine genome (UMD 3.1) from
Ensembl release 63 using the TopHat aligner (51), and gene counts were generated for each sample
using Cufﬂinks (52). Differential gene expression between challenged and control cells at each time point
was assessed using edgeR (53, 54). Brieﬂy, gene counts were ﬁltered to remove genes with zero counts
across all samples and with less than one count/million, in line with guidelines published by the edgeR
authors (55). Approximately 47% of bovine genes remained after this ﬁltering step. The data set was then
normalized using trimmed mean normalization (54). edgeR then was used to model the data across
conditions, accounting for the biological pairing between control and challenged samples from the same
animal. A likelihood ratio test was used to assess model ﬁt, and where the inclusion of the challenge
effect signiﬁcantly improved the model ﬁt, the gene was called regulated in order to generate lists of
genes that were differentially expressed in response to each mycobacterial infection compared to the
uninfected controls. The false discovery rate for differentially regulated genes was set at 1%.
Quantiﬁcation of intracellular M. bovis. Genomic DNA (gDNA) was isolated from bMDM after
infection with M. bovis at 2, 6, 24, 48, and 72 hpi using the DNeasy blood and tissue kit (Qiagen) by
following the manufacturer’s instructions, including the pretreatment of samples with lysozyme to
maximize recovery of mycobacterial DNA. The abundance of mycobacterial genome copies in each
sample was quantiﬁed by qPCR by ampliﬁcation of the M. bovis 85B antigen gene (MY85B) using the
oligonucleotides 5=-CATCAAGGTTCAGTTCCAGAGC-3= and 5=-TATCCCAGCCGTTGTAGTCG-3=. The levels of
each gene were quantiﬁed by qPCR using the PerfeCTa SYBR green qPCR supermix (Quanta Biosciences).
Reactions were carried out in 10-l volumes containing 1master mix, 1 l forward and reverse primers
at predetermined optimal concentrations, and 2.5 l gDNA sample. Ampliﬁcation and detection of
products were carried out using an Mx3000P PCR machine (Stratagene) with the following cycle proﬁle:
95°C for 3 min, followed by 40 cycles of 95°C for 10 s and 60°C for 30 s. The detection of a single product
was veriﬁed by dissociation curve analysis. Each PCR experiment was carried out in triplicate, and a log10
dilution series of a pGEM-T easy (Promega) plasmid containing MY85B sequence of known size and
concentration was included to allow extrapolation of gene copy number (GCN) in each sample.
Intracellular mycobacteria were also quantiﬁed as CFU. Cells were lysed 2, 6, 24, 48, and 72 hpi with
0.5 ml PBS plus 0.1% Triton X-100 and incubated at room temperature for 10 min. Aliquots of a 10-fold
dilution series were plated onto Middlebrook 7H11 agar plates supplemented with 10% oleic albumin
dextrose catalase (OADC) and incubated at 37°C until colonies could be accurately counted.
Validation of the RNA-Seq results by RT-qPCR. RT-qPCR was used to validate the RNA-Seq data
analysis results. A second set of time course experiments was carried out by infecting bMDM with the
two strains of M. bovis, and an additional 72-hpi time point was included. RNA was extracted using the
ReliaPrep RNA cell miniprep kit (Promega) with an on-column DNase step as directed by the manufac-
turers. RNA was quantiﬁed using a NanoDrop ND-1000 spectrophotometer (Thermo Scientiﬁc). First-
strand cDNA was reverse transcribed from 250 ng total RNA using oligo(dT) primer and GoScript reverse
transcriptase (Promega) according to the manufacturer’s instructions. The resulting cDNA was diluted
1:20 for all genes. Oligonucleotides were designed for each gene using Primer3 (56, 57) and Netprimer
(Biosoft International) software (see Table S2 in the supplemental material). The qPCRs were carried out
as described above. The relative quantities of mRNA were calculated compared to that detected in the
time 0 h uninfected controls using the method described previously (58). The RT-qPCR results for
RALBP1-associated Eps domain-containing 1 (REPS1) were used to calculate differences in the template
RNA levels and thereby standardize the results for the genes of interest. REPS1 was selected by analysis
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of the RNA-Seq data as a constitutively and moderately expressed gene in all samples, which was
conﬁrmed by RT-qPCR.
ELISA. Supernatants were collected 2, 6, 24, 48, and 72 hpi. IL-1 and IFN- protein levels in the
supernatants were quantiﬁed using the bovine IL-1 screening kit (Thermo Scientiﬁc Pierce) and bovine
IFN--speciﬁc ELISA kit (Bio-Rad), respectively, by following the manufacturers’ instructions. IL-10 protein
was quantiﬁed by ELISA using the mouse anti-bovine IL-10 antibodies CC318 and CC320 (Bio-Rad) as
coating and detecting antibodies, respectively. Both antibodies were used at 2 g/ml ﬁnal concentration.
TNF protein was quantiﬁed by ELISA using the coating antibody CC327 and the detecting antibody
CC328 (Bio-Rad) at 4 g/ml and 2 g/ml ﬁnal concentrations, respectively. The same protocol and buffers
were used in the IL-10 and TNF ELISAs as those for the IL-1 ELISA. The concentration of IL-10 and TNF
was determined using a standard curve of recombinant ovine IL-10 and bovine TNF (kindly provided by
Jayne Hope, The Roslin Institute). All ELISAs were carried out using Nunc-Immuno MaxiSorp 96-well
plates, with all samples and standards in triplicate. The plates were read at 450 nm, with the reference
values at a wavelength of 550 nm subtracted, using a Synergy HT plate reader (BioTek).
bMDM cell death assays. bMDM were prepared and infected with both M. bovis strains as described
above at an MOI of 5. Cells were harvested using TrypLE Express (Thermo Fisher) 48 hpi, and cell viability
and the mechanism of cell death were investigated. bMDM viability was assessed by staining with a
predetermined optimal concentration of Zombie NIR ﬁxable viability stain (BioLegend) (excitation/
emission wavelengths [Ex/Em], 719/746 nm) for 30 min. bMDM treated with 1% PFA for 30 min were used
as a positive control for cell death. bMDM were washed three times before being ﬁxed with 2% PFA for
30 min. The bMDM then were analyzed using a FACSCalibur (BD Biosciences) ﬂow cytometer. bMDM
were initially gated by size and granularity to exclude debris, and the amount of viability stain was
measured for a minimum of 10,000 events. The mechanism of cell death was investigated using the
apoptosis/necrosis kit (Abcam) by following the manufacturer’s instructions. Apoptotic and necrotic cells
were identiﬁed by staining with Apopxin deep red indicator (red ﬂuorescence; Ex/Em 630/660 nm), which
detects phosphatidylserine, and nuclear green DCS1 (green ﬂuorescence; Ex/Em 490/525 nm), which
labels the nuclei of membrane-permeable cells, respectively. bMDM treated with 1 M staurosporine for
18 h or 95% ethanol for 30 min were used as positive controls for apoptosis and necrosis, respectively.
bMDM were ﬁxed with 2% PFA for 30 min before analysis using an LSR Fortessa (BD Biosciences) ﬂow
cytometer. bMDM were initially gated to exclude debris and doublets, and the amount of red and green
ﬂuorescence was measured for a minimum of 10,000 events.
Inﬂammasome activation. bMDM were prepared and infected with both M. bovis strains as
described above at an MOI of 5. Cells were harvested 24 hpi using TrypLE Express (Thermo Fisher), and
inﬂammasome activity was investigated by measuring active CASP1 using the FAM FLICA caspase 1 kit
(Bio-Rad) by following the manufacturer’s instructions. bMDM were ﬁxed with 2% PFA for 30 min before
the amount of ﬂuorescent staining was measured by ﬂow cytometry analysis.
Western blots. Protein extracts were prepared using M-Per (Thermo Fisher Scientiﬁc) with protease
inhibitors. Equal volumes of supernatants were concentrated using Ultra-0.5 (10K) centrifugal ﬁlter
devices (Amicon) by following the manufacturer’s instructions. Cell lysates and concentrated superna-
tants were run on 12% SDS-PAGE gels and blotted onto nitrocellulose. Western blot analyses were
performed using primary rabbit antibodies against sheep IL-1 (AHP423; 1:250; Bio-Rad) and human
-actin (ab8227; 1:1,000; Abcam). A goat anti-rabbit IgG antibody conjugated with horseradish peroxi-
dase (HRP) (HAF008; 1:1,000; R&D Systems) was used as a secondary antibody with SuperSignal West Pico
chemiluminescent substrate (Thermo Fisher Scientiﬁc).
Statistical analysis. All statistical analyses, other than the analysis of the RNA-Seq data, were carried
out using Minitab, version 17. The data were transformed on the log10 scale before statistical analyses to
stabilize the variance. Changes in gene expression in infected samples compared to resting cells were
analyzed by t test corrected for multiple testing (Benjamini-Hochberg). Comparison of the responses of
bMDM to the two different M. bovis strains across the time course was analyzed using the general linear
model (GLM) to allow repeated-measure analysis, ﬁtting biological replicate as a random effect, with time
postinfection and M. bovis strain as ﬁxed effects. Subsequent Fisher’s tests were used to identify
signiﬁcant differences between M. bovis strains, as well as the interaction between M. bovis strain and
time postinfection.
Accession number(s). The RNA-Seq data are publicly available at GEO under the accession number
GSE104211.
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